Health ❯ Healthcare ❯ Vaccines

Influenza

H3N2 Public Health Thimerosal Vaccine Recommendations Universal Influenza Vaccine Influenza A (H3N2) Flu Symptoms Vaccine Advisory Committee Vaccine Effectiveness FluMist Home FluMist

FDA Advisers Back 2026–27 Flu Shot Overhaul to Target Dominant H3N2 Variant

The recommendation mirrors WHO strains, with a final decision pending from FDA Commissioner Martin Makary.

AstraZeneca Launches FluMist Home Direct-to-Consumer Nasal Vaccine in 34 States